The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

Most of us know someone that has been affected by diabetes. It can lead to severe health problems, such as eye problems, ...

Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.